Frank Takkinen
Stock Analyst at Lake Street
(0.46)
# 4,153
Out of 4,504 analysts
688
Total ratings
39.9%
Success rate
-2%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Reiterated: Buy | $6 | $4.06 | +47.78% | 11 | Jul 6, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $5 | $4.11 | +21.65% | 8 | Jul 6, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $14 | $5.43 | +157.83% | 45 | Jul 6, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2.5 | $1.09 | +129.36% | 19 | Jul 1, 2026 | |
| AORT Artivion | Reiterated: Buy | $45 | $24.09 | +86.80% | 36 | Jun 29, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $8 | $4.14 | +93.24% | 21 | Jun 25, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $20 | $17.03 | +17.44% | 12 | Jun 24, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $30 | $17.50 | +71.43% | 49 | Jun 23, 2026 | |
| NSPR InspireMD | Reiterated: Buy | $4 | $0.72 | +455.56% | 15 | Jun 11, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $20 | $17.11 | +16.89% | 48 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $10.53 | +118.42% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.57 | +601.75% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.963 | +419.21% | 30 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $15.94 | +31.74% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.70 | +135.29% | 38 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $23.82 | +34.34% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.847 | +136.13% | 37 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.01 | +66.39% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $15.41 | +224.46% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.60 | +42.86% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.28 | +86.92% | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $102.74 | +31.40% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.54 | +159.74% | 17 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $40.58 | +23.21% | 13 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.32 | +125.56% | 25 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $97.20 | +23.46% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $1.5 | $0.018 | +8,233.33% | 38 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $9.77 | +53.53% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.79 | +87.65% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.6833 | +778.09% | 17 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $51.76 | +189.80% | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $4.38 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.44 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $5.60 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.68 → $19.84 | $10.05 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.000001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $12 | $0.1299 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $3.01 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $10 | $4.30 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.67 | $0.33 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0001 | n/a | 3 | Mar 31, 2022 |
AVITA Medical
Jul 6, 2026
Reiterated: Buy
Price Target: $6
Current: $4.06
Upside: +47.78%
MiMedx Group
Jul 6, 2026
Reiterated: Buy
Price Target: $5
Current: $4.11
Upside: +21.65%
CVRx, Inc.
Jul 6, 2026
Reiterated: Buy
Price Target: $14
Current: $5.43
Upside: +157.83%
Hyperfine
Jul 1, 2026
Reiterated: Buy
Price Target: $2.5
Current: $1.09
Upside: +129.36%
Artivion
Jun 29, 2026
Reiterated: Buy
Price Target: $45
Current: $24.09
Upside: +86.80%
TriSalus Life Sciences
Jun 25, 2026
Reiterated: Buy
Price Target: $8
Current: $4.14
Upside: +93.24%
Beta Bionics
Jun 24, 2026
Reiterated: Buy
Price Target: $20
Current: $17.03
Upside: +17.44%
ClearPoint Neuro
Jun 23, 2026
Reiterated: Buy
Price Target: $30
Current: $17.50
Upside: +71.43%
InspireMD
Jun 11, 2026
Reiterated: Buy
Price Target: $4
Current: $0.72
Upside: +455.56%
NeuroPace
May 29, 2026
Reiterated: Buy
Price Target: $20
Current: $17.11
Upside: +16.89%
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $10.53
Upside: +118.42%
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.57
Upside: +601.75%
May 15, 2026
Reiterated: Buy
Price Target: $5
Current: $0.963
Upside: +419.21%
May 15, 2026
Reiterated: Buy
Price Target: $21
Current: $15.94
Upside: +31.74%
May 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.70
Upside: +135.29%
May 13, 2026
Reiterated: Buy
Price Target: $32
Current: $23.82
Upside: +34.34%
May 13, 2026
Reiterated: Buy
Price Target: $2
Current: $0.847
Upside: +136.13%
May 11, 2026
Reiterated: Buy
Price Target: $10
Current: $6.01
Upside: +66.39%
May 8, 2026
Reiterated: Buy
Price Target: $50
Current: $15.41
Upside: +224.46%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $5.60
Upside: +42.86%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $4.28
Upside: +86.92%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $102.74
Upside: +31.40%
Apr 30, 2026
Reiterated: Buy
Price Target: $4
Current: $1.54
Upside: +159.74%
Apr 28, 2026
Reiterated: Buy
Price Target: $50
Current: $40.58
Upside: +23.21%
Mar 30, 2026
Reiterated: Buy
Price Target: $12
Current: $5.32
Upside: +125.56%
Feb 11, 2026
Reiterated: Buy
Price Target: $100 → $120
Current: $97.20
Upside: +23.46%
Feb 10, 2026
Maintained: Buy
Price Target: $3 → $1.5
Current: $0.018
Upside: +8,233.33%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $9.77
Upside: +53.53%
Jan 7, 2026
Reiterated: Buy
Price Target: $24
Current: $12.79
Upside: +87.65%
Oct 7, 2025
Reiterated: Buy
Price Target: $6
Current: $0.6833
Upside: +778.09%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $51.76
Upside: +189.80%
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $4.38
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $5.44
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $5.60
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.68 → $19.84
Current: $10.05
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.000001
Upside: n/a
Feb 14, 2023
Maintained: Buy
Price Target: $4 → $12
Current: $0.1299
Upside: n/a
Sep 29, 2022
Maintained: Buy
Price Target: $1
Current: $3.01
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $14 → $10
Current: $4.30
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.67
Current: $0.33
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0001
Upside: n/a